Gland Pharma Limited GLAND

Latest filings

• M&A73 13 Sept, 16:37 · NSE
  Acquisition of 100% of the equity share capital of Gland Pharma USA Inc. , a wholly-owned step down subsidiary of the Company, from Gland Pharma International Pte
• Board meeting50 13 Sept, 16:27 · NSE
  Outcome of Board Meeting held on September 13, 2026.
• Routine15 13 Sept, 15:39 · NSE
  Allotment of 44,193 Equity Shares on exercise of ESOPs
• Routine15 13 Sept, 15:34 · BSE
  Grant of Stock Options under Gland Pharma Employee Stock Option Scheme, 2025
• Board meeting45 13 Sept, 15:33 · NSE
  Options to purchase securities
• Board meeting45 13 Sept, 15:27 · NSE
  Board comments on fines levied by the Exchanges
• Routine15 10 Sept, 17:43 · NSE
  Schedule of meet
• Routine15 8 Sept, 19:45 · NSE
  Schedule of meet
• Insider / SAST45 8 Sept, 12:46 · BSE
  The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fosun Pharma Industrial Pte Ltd
• Routine15 4 Sept, 14:53 · NSE
  Schedule of meet

Shown 15 minutes after publication. Real time with Pro.

Upcoming corporate actions

No announced actions in the next 60 days.